CIABATTONI, Giovanni
 Distribuzione geografica
Continente #
NA - Nord America 3.958
EU - Europa 3.406
AS - Asia 2.159
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 3
AF - Africa 1
SA - Sud America 1
Totale 9.537
Nazione #
US - Stati Uniti d'America 3.947
UA - Ucraina 805
CN - Cina 712
SG - Singapore 654
TR - Turchia 630
IE - Irlanda 605
GB - Regno Unito 519
SE - Svezia 495
FR - Francia 313
DE - Germania 232
FI - Finlandia 170
IN - India 140
RU - Federazione Russa 119
IT - Italia 118
CZ - Repubblica Ceca 11
CA - Canada 9
EU - Europa 9
IL - Israele 6
IR - Iran 6
PL - Polonia 6
AU - Australia 3
BE - Belgio 3
TW - Taiwan 3
VN - Vietnam 3
AT - Austria 2
LT - Lituania 2
MX - Messico 2
CL - Cile 1
EG - Egitto 1
IM - Isola di Man 1
JO - Giordania 1
KG - Kirghizistan 1
KR - Corea 1
LI - Liechtenstein 1
MK - Macedonia 1
MO - Macao, regione amministrativa speciale della Cina 1
NO - Norvegia 1
PK - Pakistan 1
RO - Romania 1
RS - Serbia 1
Totale 9.537
Città #
Jacksonville 857
Chandler 740
Dublin 602
Singapore 584
Southend 454
Princeton 314
Izmir 310
Nanjing 202
Wilmington 184
Santa Clara 152
Cambridge 143
Dearborn 132
Ashburn 131
Beijing 123
Nanchang 74
Woodbridge 68
Ann Arbor 60
Boardman 58
Shenyang 45
Altamura 40
New York 36
Hebei 34
Kunming 34
Tianjin 34
Grevenbroich 33
Washington 32
Los Angeles 30
Changsha 28
Helsinki 28
Jiaxing 28
Norwalk 24
Moscow 22
Hangzhou 17
Munich 17
Houston 16
Orange 15
Chieti 14
Falls Church 14
Augusta 13
Jinan 13
San Mateo 13
Brno 10
Seattle 9
Changchun 8
Lanzhou 8
Zhengzhou 8
Auburn Hills 7
Leawood 7
Ningbo 5
Pune 5
Taiyuan 5
Toronto 5
Mountain View 4
Perugia 4
Shanghai 4
Tappahannock 4
Anzola Dell'emilia 3
Brussels 3
Fuzhou 3
Hefei 3
Kraków 3
Ottawa 3
Pescara 3
Roseto degli Abruzzi 3
Taipei 3
Taizhou 3
Walnut 3
Cedar Knolls 2
Chaoyang 2
Dong Ket 2
Frankfurt am Main 2
Hillsborough 2
Kocaeli 2
London 2
Mexico City 2
Milan 2
Naples 2
Rome 2
Roseto Degli Abruzzi 2
San Jose 2
Secaucus 2
Simi Valley 2
Teramo 2
Tortoreto 2
Warsaw 2
Wuhan 2
Adelaide 1
Andover 1
Ardabil 1
Bangalore 1
Belgrade 1
Bishkek 1
Buffalo 1
Cairo 1
Casalbordino 1
Chengdu 1
Chicago 1
Chongqing 1
Douglas 1
Durham 1
Totale 5.946
Nome #
Postprandial hyperglycemia is a determinant of platelet activation in early type 2 diabetes mellitus 126
Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus: role of interleukin-6 and disease duration. 117
Soluble CD40L in Mediterranean Spotted Fever: relation to oxidative stress and platelet activation 115
Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus 105
Platelet Cyclooxygenase Inhibition by Low-Dose Aspirin Is Not Reflected Consistently by Platelet Function Assays. Implications for Aspirin "Resistance" 104
Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays. implications for aspirin 'resistance'. 100
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) sequentially upregulates nitric oxide and prostanoid production in primary human endothelial cells. 98
Determinants of platelet activation in hypertensives with microalbuminuria. 98
Helicobacter pylori infection causes persistent platelet activation in vivo through enhanced lipid peroxidation 98
8-Isoprostane in exhaled breath condensate (EBC)and excercise-induced bronchoconstriction in asthmatic children and adolescents 97
Amylin inhibits hypothalamic dopamine release. 96
Vitamin E inhibits enhanced F2 isoprostane biosynthesis in type IIA hypercholesterolemia 94
Decreased plasma soluble RAGE in patients with hypercholesterolemia: effects of statins. 92
The contribution of cyclooxygenase-1 and -2 to persistent thromboxane biosynthesis in aspirin-treated essential thrombocythemia: implications for antiplatelet therapy. 92
Effects of atorvastatin and rosuvastatin on thromboxane-dependent platelet activation and oxidative stress in hypercholesterolemia. 90
Decreased in vivo oxidative stress and decreased platelet activation following metformin treatment in newly diagnosed type 2 diabetes subjects 89
Decreased plasma soluble RAGE in patients with hypercholesterolemia: effects of statins. 89
A Polymorphism in the Cyclooxygenase 2 Gene as an Inherited Protective Factor Against Myocardial Infarction and Stroke 88
Cyclooxygenase-1, but not -2, is upregulated in NB4 leukemic cells and human primary promyelocytic blasts during neutrophil granulocytic differentiation and contributes to maturation. 88
Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: implications for aspirin "resistance". 87
Inhibition of thromboxane biosynthesis by triflusal in type 2 diabetes mellitus. 86
Aging increases amyloid beta-peptide-induced 8-iso-prostaglandin F2alpha release from rat brain. 85
Tachykinin-eicosanoid crosstalk in airway inflammation 84
Problemi di metodologia per la individuazione del rischio tossicologico. Consiglio Nazionale delle Ricerche 84
Chromatin derived acid peptides inhibit dopamine and norepinephrine release in the hypothalamus. 83
Increased exhaled 8-isoprostane in childhood asthma. 81
Insulin resistance as a determinant of platelet activation in obese women. 81
Platelets as a source of CD40 ligand in type 2 diabetes mellitus 81
Determinants of platelet activation in Alzheimer's disease 81
Determinants of thromboxane biosynthesis in rheumatoid arthritis: Role of RAGE and oxidant stress. 80
Decreased plasma soluble rage in patients with hypercholesterolemia: effects of statins. 80
In vivo formation of 8-epi-prostaglandin F2alpha in diabetes mellitus. Effects of tight metabolic control and vitamin E supplementation. (pubbl su Suppl Thromb Haemostas) 79
In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation. 79
Measurement of 8-isoprostane in exhaled breath condensate. 79
Platelet Activation and Lipid Peroxidation in Patients With Acute Ischemic Stroke. 78
Effect of CART peptide-(55-102), leptin and orexin-B on hypothalamicserotonin release. 78
In vivo formation of 8-Epi-prostaglandin F2 alpha is increased in hypercholesterolemia. 78
Soluble RAGE in type 2 diabetes: association with oxidative stress. 78
Abnormal pH-sensing of platelet Na+/H+ exchanger in patients with cardiac syndrome X 77
Postprandial hyperglycemia is an important determinant of platelet activation. evidence from biochemical measurements and pharmacological intervention with acarbose 77
Determinants of platelet activation in hypertensives with microalbuminuria. 77
Anterior pituitary cell production of 8-iso-prostaglandin F2alpha. 76
Differential Expression and Regulation of Cyclooxygenase Isozymes in Thymic Stromal Cells. 76
Effects of anthracyclines on hypothalamic dopamine release. 75
Thromboxane and prostacyclin biosynthesis in heart failure of ischemic origin: effects of disease severity and aspirin treatment. 75
Immunological characterization uf urinary 8-epi-prostaglandin f2alfa excretion in man 74
Cyclooxygenase-2 expression is induced during human megakaryopoiesis and characterizes newly formed platelets. 74
Postprandial hyperglycemia is an important determinant of platelet activation in early type 2 diabetes mellitus. Evidence from biochemical measurements and pharmacological intervention with acarbose. 73
Effects of atorvastatin and rosuvastatin on thromboxane-dependent platelet activation and oxidative stress in hypercholesterolemia. 73
Induced sputum, exhaled breath condensate and nasal lavage fluid in electroplating workers exposed to chromium 72
Acute, short-term hyperglycemia enhances shear stress-induced platelet activation in patients with type II diabetes mellitus. 72
In vivo formation of 8-epi-prostaglandin F2alpha in diabetes mellitus. Effects of tight metabolic control and vitamin E supplementation 72
Exhaled 8-Isoprostane as an In Vivo Biomarker of Lung Oxidative Stress in Patients with COPD and Healthy Smokers 71
Modulation of the expression and activity of cyclooxygenases in normal and accelerated erytrhopoiesis. 71
Effects of Acarbose on in Vivo Markers of Oxidative Stress and Platelet Activation in Early Type 2 Diabetes 71
Increased thromboxane biosynthesis in essential thrombocythemia 70
Association between PAI-1 and Oxidative Stress in Android Obesity 70
Attivazione piastrinica e stress ossidativo in vivo nell’artrite reumatoide. 70
Increased macrothrombocytopenia with distinctive platelet ultrastructural and functional features 69
Acute effects of air pollution on pulmonary function, airway inflammation, and oxidative stress in asthmatic children. 69
In vivo formation of 8-epi-prostaglandin F2alpha in increased in hypercholesterolemia. An aspirin-insensitive amplification mechanism of platelet activation (pubbl su Suppl Thromb Haemostas) 68
Validation of 8-isoprostane and prostaglandin E2 measurements in exhaled breath condensate. 68
Effects of montelukast treatment and withhdrawal on fractional exhaled nitric oxide and lung function in children with asthma 68
Low-density lipoprotein level reduction by the 3-hydroxy-3-methylglutaryl coenzima-A inhibitor sinvastatin is accompanied by a related reduction of F2-isoprostane formation in hypercholesterolemic subjects: no further effect of vitamin E. 68
Circulating MRP 8/14 is Associated with Thromboxane Dependent Platelet Activation in NSTEMI Patients: Effect of Aspirin Treatment 68
Decreased plasma levels of soluble receptor for advanced glycation end products in type 2 diabetes mellitus: association with oxidative stress and metabolic control. 68
Soluble CD40L as an indicator of platelet Activation in Heart Failure 68
Thromboxane and prostacyclin biosynthesis in heart failure of ischemic origin: effects of disease severity and aspirin treatment. 68
Soluble CD40L in Mediterranean Spotted Fever: Relation to oxidative stress and platelet activation. 68
Platelet Activation Markers in Patients with Peripheral Arterial Disease. A Prospective Comparison of Different Platelet Function Tests 68
Role of Platelet Activation in Dementia 67
Validation of leukotriene B4 measurements in exhaled breath condensate. 67
Tachykinin-eicosanoid crosstalk in airway inflammation 66
Insulin resistance as a determinant of platelet activation in obese women 66
Identification of 8-iso-prostaglandin (PG) F2alfa in rat brain neuronal endings: a possible marker of membrane phospholipid peroxidation. 65
Thromboxane-dependent CD40L release in type 2 diabetes mellitus 65
Fluvastatin reduces soluble P-selectin and ICAM-1 levels in hypercholesterolemic patients: role of nitric oxide 64
Platelet activation in obese women: role of inflammation and oxidant stress. 64
Effects of Acarbose on in Vivo Markers of Oxidative Stress and Platelet Activation in Early Type 2 Diabetes. 64
Decreased plasma levels of soluble receptor for advanced glycation end products in type 2 diabetes mellitus: association with oxidative stress and metabolic control 64
Prognostic significance of cyclooxygenase-2 in laryngeal squamous cell carcinoma. 63
Effects of cocaine- and amphetamine-regulated transcript peptide, leptin and orexins on hypothalamic serotonin release. 63
Oxidative Stress and Platelet Activation in Subjects with Moderate Hyperhomocysteinemia Due to MTHFR 677 C->T Polymorphism. 63
Insulin resistance and platelet activation in obese women 63
Inherited Macrothrombocytopenia with Distinctive Platelet Ultrastructural and Functional Features 62
Effect of gherlin and amylin on hypothalamic dopamine, norepinephrine and serotonin release. 62
Enhanced Lipid Peroxidation and Platelet Activation as Potential Contributors to Increased Cardiovascular Risk in the “Low-HDL” Phenotype 62
Signaling pathways involved in lipopolysaccharide stimulation of prostaglandin production by rat hypothalamic astroglial cells 60
Anaphylaxis increases 8-iso-PGF2alpha release from guinea-pig lung in vitro 60
Effects of atorvastatin and rosuvastatin on throboxane-dependent platelet activation and oxidative stress in hypercholesterolemia. 60
Drugs, prostaglandins, and renal function. 60
Determinants of Platelet Activation in Heart Failure. 60
Insulin resistance as a determinant of platelet activation in obese women 60
Thromboxane and prostacyclin biosynthesis in heart failure of ischemic origin: effects of disease severity and aspirin treatment. 60
Determinants of Platelet Activation in Heart Failure. 60
TNF-related apoptosis-inducing ligand (TRAIL) up-regulates cyclooxygenase (COX)-1 activity and PGE2 production in cells of the myeloid lineage. 59
In vivo formation of 8-iso-prostaglandin F2a and aspirin-insensitive thromboxane biosynthesis in unstable angina 58
Exhaled leukotrienes and prostaglandins in COPD. 58
Effects of successful weight loss or pioglitazone on thromboxane-dependent platelet activation in obese women 58
Thromboxane biosynthesis and metabolism in relation to cardiovascular risk factors 58
Totale 7.563
Categoria #
all - tutte 35.838
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.838


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020740 0 0 0 0 0 0 187 199 28 143 175 8
2020/2021872 145 6 146 0 91 198 2 7 85 151 8 33
2021/2022598 17 7 4 118 71 9 11 43 45 11 78 184
2022/20231.930 159 197 126 222 189 447 115 134 233 19 39 50
2023/2024801 62 33 60 22 48 256 216 25 2 7 9 61
2024/20251.259 149 524 484 28 19 55 0 0 0 0 0 0
Totale 9.785